Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131563) titled 'Single-center, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of Clostridium Butyricum Capsules (Misan) in the Treatment of Hyperuricemia' on Sept. 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Third Affiliated Hospital of Southern Medical University

Condition: hyperuricemia

Intervention: Test group:Take the investigational drug "Clostridium butyricum Live Bacteria Capsules" orally, two capsules each time, three times a day,take orally after the meal

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment:...